Pharma's Godfather Moment: Pulled Back Into Tariff Uncertainty
Source: SeekingAlpha
2026-03-13 10:35:00 ET
By Diederik Stadig , Senior Economist, Healthcare & Technology
'Just when I thought I was out...'
Just as 16 branded pharma companies struck investment deals with the Administration – trading MFN pricing for a temporary reprieve on tariffs – the US Supreme Court ruling marked the start of a messy transition period. In response, the Administration invoked Section 122 of the 1974 Trade Act, which permits tariffs of up to 15% for as long as 150 days, with the possibility of extensions....
Read the full article on Seeking Alpha
For further details see:
Pharma's Godfather Moment: Pulled Back Into Tariff Uncertainty
SPDR S&P Pharmaceuticals
NASDAQ: XPH
XPH Trading
-2.72% G/L:
$52.36 Last:
10,141 Volume:
$53.19 Open:
